Approvals/TGA/AKYNZEO IV fosnetupitant (as chloride hydrochloride)/palonosetron (as hydrochloride) 235 mg/250 microgram concentrated injection vial

Approved

STANDARD

AKYNZEO IV fosnetupitant (as chloride hydrochloride)/palonosetron (as hydrochloride) 235 mg/250 microgram concentrated injection vial

Juniper Biologics Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 1639d222c06f94d6
Product Name: AKYNZEO IV fosnetupitant (as chloride hydrochloride)/palonosetron (as hydrochloride) 235 mg/250 microgram concentrated injection vial
Artg Id: 349310
Artg Name: AKYNZEO IV fosnetupitant (as chloride hydrochloride)/palonosetron (as hydrochloride) 235 mg/250 microgram concentrated injection vial
Sponsor: Juniper Biologics Pty Ltd
Company Detail Path: /organization/juniper-biologics-pty-ltd
Artg Date: 2022-01-28
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/34c1e54545e8d23513fa40b7a84872f5.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/345437e5391dc97349db09aa9afa9f1b.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

1639d222c06f94d6

Type

Standard